Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 260

Similar articles for PubMed (Select 21775467)

1.

Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent FcγR pathway.

Jaume M, Yip MS, Cheung CY, Leung HL, Li PH, Kien F, Dutry I, Callendret B, Escriou N, Altmeyer R, Nal B, Daëron M, Bruzzone R, Peiris JS.

J Virol. 2011 Oct;85(20):10582-97. doi: 10.1128/JVI.00671-11. Epub 2011 Jul 20.

2.

SARS CoV subunit vaccine: antibody-mediated neutralisation and enhancement.

Jaume M, Yip MS, Kam YW, Cheung CY, Kien F, Roberts A, Li PH, Dutry I, Escriou N, Daeron M, Bruzzone R, Subbarao K, Peiris JS, Nal B, Altmeyer R.

Hong Kong Med J. 2012 Feb;18 Suppl 2:31-6.

3.

Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins.

Wang SF, Tseng SP, Yen CH, Yang JY, Tsao CH, Shen CW, Chen KH, Liu FT, Liu WT, Chen YM, Huang JC.

Biochem Biophys Res Commun. 2014 Aug 22;451(2):208-14. doi: 10.1016/j.bbrc.2014.07.090. Epub 2014 Jul 26.

PMID:
25073113
4.

Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRII-dependent entry into B cells in vitro.

Kam YW, Kien F, Roberts A, Cheung YC, Lamirande EW, Vogel L, Chu SL, Tse J, Guarner J, Zaki SR, Subbarao K, Peiris M, Nal B, Altmeyer R.

Vaccine. 2007 Jan 8;25(4):729-40. Epub 2006 Aug 22.

PMID:
17049691
5.

Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus.

Yip MS, Leung NH, Cheung CY, Li PH, Lee HH, Daëron M, Peiris JS, Bruzzone R, Jaume M.

Virol J. 2014 May 6;11:82. doi: 10.1186/1743-422X-11-82.

6.

S protein of severe acute respiratory syndrome-associated coronavirus mediates entry into hepatoma cell lines and is targeted by neutralizing antibodies in infected patients.

Hofmann H, Hattermann K, Marzi A, Gramberg T, Geier M, Krumbiegel M, Kuate S, Uberla K, Niedrig M, Pöhlmann S.

J Virol. 2004 Jun;78(12):6134-42.

7.

SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway.

Wang H, Yang P, Liu K, Guo F, Zhang Y, Zhang G, Jiang C.

Cell Res. 2008 Feb;18(2):290-301. doi: 10.1038/cr.2008.15.

8.

[Potent neutralization antibody elicited in mice by SARS-associated coronavirus spike protein S1 domain].

Zhang Y, Yang F, Li YH, Li WH, Tu XM, Wei Q, Zhu H, Liu L, Wang H, Qin C, Yuan GY, He W, Wang SH.

Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2004 Sep;18(3):258-60. Chinese.

PMID:
15640862
9.

Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants.

ter Meulen J, van den Brink EN, Poon LL, Marissen WE, Leung CS, Cox F, Cheung CY, Bakker AQ, Bogaards JA, van Deventer E, Preiser W, Doerr HW, Chow VT, de Kruif J, Peiris JS, Goudsmit J.

PLoS Med. 2006 Jul;3(7):e237.

10.

Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV.

Liu YV, Massare MJ, Barnard DL, Kort T, Nathan M, Wang L, Smith G.

Vaccine. 2011 Sep 2;29(38):6606-13. doi: 10.1016/j.vaccine.2011.06.111. Epub 2011 Jul 14.

11.
12.

Pseudotyped vesicular stomatitis virus for analysis of virus entry mediated by SARS coronavirus spike proteins.

Fukushi S, Watanabe R, Taguchi F.

Methods Mol Biol. 2008;454:331-8. doi: 10.1007/978-1-59745-181-9_23.

PMID:
19057867
13.

Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2.

Matsuyama S, Nagata N, Shirato K, Kawase M, Takeda M, Taguchi F.

J Virol. 2010 Dec;84(24):12658-64. doi: 10.1128/JVI.01542-10. Epub 2010 Oct 6.

14.

Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response.

Glowacka I, Bertram S, Müller MA, Allen P, Soilleux E, Pfefferle S, Steffen I, Tsegaye TS, He Y, Gnirss K, Niemeyer D, Schneider H, Drosten C, Pöhlmann S.

J Virol. 2011 May;85(9):4122-34. doi: 10.1128/JVI.02232-10. Epub 2011 Feb 16.

16.

Effects of human anti-spike protein receptor binding domain antibodies on severe acute respiratory syndrome coronavirus neutralization escape and fitness.

Sui J, Deming M, Rockx B, Liddington RC, Zhu QK, Baric RS, Marasco WA.

J Virol. 2014 Dec;88(23):13769-80. doi: 10.1128/JVI.02232-14. Epub 2014 Sep 17.

17.

Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model.

Du L, Zhao G, He Y, Guo Y, Zheng BJ, Jiang S, Zhou Y.

Vaccine. 2007 Apr 12;25(15):2832-8. Epub 2006 Oct 30.

PMID:
17092615
18.

A chimeric multi-epitope DNA vaccine elicited specific antibody response against severe acute respiratory syndrome-associated coronavirus which attenuated the virulence of SARS-CoV in vitro.

Wang X, Xu W, Tong D, Ni J, Gao H, Wang Y, Chu Y, Li P, Yang X, Xiong S.

Immunol Lett. 2008 Aug 15;119(1-2):71-7. doi: 10.1016/j.imlet.2008.04.005. Epub 2008 May 19.

PMID:
18533276
19.

SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells.

Huang IC, Bosch BJ, Li F, Li W, Lee KH, Ghiran S, Vasilieva N, Dermody TS, Harrison SC, Dormitzer PR, Farzan M, Rottier PJ, Choe H.

J Biol Chem. 2006 Feb 10;281(6):3198-203. Epub 2005 Dec 8.

20.

Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein.

Fukushi S, Mizutani T, Saijo M, Matsuyama S, Miyajima N, Taguchi F, Itamura S, Kurane I, Morikawa S.

J Gen Virol. 2005 Aug;86(Pt 8):2269-74.

PMID:
16033974
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk